CSRC approved the IPO registration of Shenghe Jingwei Microtechnology Innovation Board.
On March 5th, the China Securities Regulatory Commission issued the "Reply on Approving Shanghai Simgui Technology Co., Ltd.'s Initial Public Offering of Stocks Registration".
On March 5th, the China Securities Regulatory Commission issued the approval for the initial public offering of Shenghe Jingwei Semiconductor Co., Ltd. It is reported that Shenghe Jingwei plans to go public on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with China International Capital Corporation Limited as its sponsoring institution, aiming to raise 4.8 billion yuan.
According to the prospectus, Shenghe Jingwei is a leading global integrated circuit wafer-level advanced packaging and testing company, starting with advanced 12-inch mid-stage silicon wafer processing, and further providing full-process advanced packaging and testing services such as wafer-level packaging (WLP) and chip multi-chip integration packaging, dedicated to supporting various high-performance chips, especially graphics processors (GPU), central processors (CPU), artificial intelligence chips, etc., through heterogeneous integration beyond Moore's Law, achieving comprehensive performance improvements in high computing power, high bandwidth, low power consumption, etc.
Related Articles

PepsiCo, Inc. localizes over 90% of its raw materials to strengthen hedging against risks from GEO Group Inc

Zhejiang Starry Pharmaceutical (603520.SH) plans to acquire a 20% stake in Rui Shi Pharmaceutical for 10 million yuan to increase CMO production capacity.

Don't be scared by panic! The conflict in the Middle East has created a "golden buying opportunity". Are these two high-yield blue-chip stocks worth investing in with your eyes closed?
PepsiCo, Inc. localizes over 90% of its raw materials to strengthen hedging against risks from GEO Group Inc

Zhejiang Starry Pharmaceutical (603520.SH) plans to acquire a 20% stake in Rui Shi Pharmaceutical for 10 million yuan to increase CMO production capacity.

Don't be scared by panic! The conflict in the Middle East has created a "golden buying opportunity". Are these two high-yield blue-chip stocks worth investing in with your eyes closed?






